Molecular prognostic tumor profiling of type 1 and type 2 papillary renal cell carcinoma: Relevance to the development of tumor-specific targeted therapies

被引：0
|
作者：
Klatte, Tobias
Said, Jonathan W.
Seligson, David
LaRochelle, Jeffrey
Shuch, Brian
Kabbinavar, Fairooz F.
Zisman, Amnon
Pantuck, Allan J.
Belldegrun, Arie S.
机构：
来源：
JOURNAL OF UROLOGY | 2008年 / 179卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(08)60613-8
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：213 / 213
页数：1
相关论文
共 50 条
  • [1] Cytogenetic and Molecular Tumor Profiling for Type 1 and Type 2 Papillary Renal Cell Carcinoma
    Klatte, Tobias
    Pantuck, Allan J.
    Said, Jonathan W.
    Seligson, David B.
    Rao, Nagesh P.
    LaRochelle, Jeffrey C.
    Shuch, Brian
    Zisman, Amnon
    Kabbinavar, Fairooz F.
    Belldegrun, Arie S.
    CLINICAL CANCER RESEARCH, 2009, 15 (04) : 1162 - 1169
  • [2] PROFILING THE TUMOR IMMUNE MICROENVIRONMENT OF PAPILLARY RENAL CELL CARCINOMA
    Mitch, Hayes
    Kirill, Sabitov
    Alex, Soupir
    Taylor, Peak
    Jonathan, Nguyen
    Carlos, Moran-Segura
    Daryoush, Saeed-Vafa
    Neale, Lopez-Blanco
    Ramos, Echevarria Paola M.
    Jodi, Balasi
    Jasreman, Dhillon
    Youngchul, Kim
    James, Mule
    Brooke, Fridley
    Brandon, Manley
    Christopher, Guske
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2024, 42 : S6 - S6
  • [3] HERPESVIRUS TYPE 2 INDUCED, TUMOR-SPECIFIC ANTIGEN IN CERVICAL CARCINOMA
    AURELIAN, L
    DAVIS, HJ
    JULIAN, CG
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 1973, 98 (01) : 1 - 9
  • [4] Survival Analysis in Patients with Papillary Renal Cell Carcinoma (PRCC): Assessing the Utility of Type 1 and Type 2 Tumor Subtyping
    Ledezma, R. A.
    Negron, E.
    Steinberg, Z.
    Paner, G. P.
    Eggener, S. E.
    MODERN PATHOLOGY, 2014, 27 : 243A - 243A
  • [5] Survival Analysis in Patients with Papillary Renal Cell Carcinoma (PRCC): Assessing the Utility of Type 1 and Type 2 Tumor Subtyping
    Ledezma, R. A.
    Negron, E.
    Steinberg, Z.
    Paner, G. P.
    Eggener, S. E.
    LABORATORY INVESTIGATION, 2014, 94 : 243A - 243A
  • [6] Differential proteins profiling in the clear cell type and papillary type of renal cell carcinoma
    Park, Hyo-Jin
    Hwa, Jeong Seok
    Kim, Choong Won
    MOLECULAR & CELLULAR PROTEOMICS, 2004, 3 (10) : S44 - S44
  • [7] Cytogenetic features, clinical significance and prognostic impact of type 1 and type 2 papillary renal cell carcinoma
    Antonelli, Alessandro
    Tardanico, Regina
    Balzarini, Piera
    Arrighi, Nicola
    Perucchini, Laura
    Zanotelli, Tiziano
    Cozzoli, Alberto
    Zani, Danilo
    Cunico, Sergio Cosciani
    Simeone, Claudio
    CANCER GENETICS AND CYTOGENETICS, 2010, 199 (02) : 128 - 133
  • [8] TUMOR-SPECIFIC ANTIBODIES IN OCULAR MELANOMA AND THEIR RELATIONSHIP TO TUMOR-CELL TYPE
    SHEIKH, KM
    BROWNSTEIN, S
    LEWIS, MG
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1975, 16 (MAR): : 199 - 199
  • [9] ACTION OF TARGETED THERAPY ON PAPILLARY RENAL CELL CARCINOMA TUMOR MODELS
    Culp, Stephen H.
    Zhang, Xiu-Ying
    Maity, Tapati
    Wood, Christopher G.
    JOURNAL OF UROLOGY, 2010, 183 (04): : E33 - E34
  • [10] Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma
    Yue Wang
    Xi Tian
    Shu-Xuan Zhu
    Wen-Hao Xu
    Aihetaimujiang Anwaier
    Jia-Qi Su
    Hua-Lei Gan
    Yuan-Yuan Qu
    Jian-Yuan Zhao
    Hai-Liang Zhang
    Ding-Wei Ye
    World Journal of Surgical Oncology, 21
12345